Health Care: Drugs

Merrimack Pharmaceuticals Inc (MACK: NASDAQ)

$3.3 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.30
52 Week High 7.14
52 Week Low 2.83
Avg. Daily Vol. (Mil) 2.07
Beta (3 year) 2.48
Share Related Items
Mkt Cap (Mil) 437.01
Shares Out (Mil) 132.43
Float (Mil) 107.11
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.20
Current Ratio 0.40
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 3.55
Price/Book 0.00
Price/Cash Flow -3.10
Per Share Data
Earnings -1.11
Sales 0.93
Book Value 0.00
Cash Flow -1.05
Business Summary
Merrimack Pharmaceuticals Inc is a biotechnology company. It discovers, develops, and commercializes innovative medicines consisting of novel therapeutics paired with diagnostics to treat various types of cancer.
General Information
One Kendall Square
Suite B7201
Cambridge, MA 02139
Industry : Drugs
Sector: Health Care
Employees: 294
CEO: Dr. Richard Peters, M.D.
Short Interest
Current Month (Mil) 22.37
Previous Month (Mil) 24.94
Short Interest Ratio (Days) 14.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -211.30
Return on Investments 251.30
Gross Margin 99.80
EBIT Margin -87.00
Profit Margin 0.00

Portfolios with MACK

Latest MACK Headlines from TheStreet

More Financial News for MACK

Press Releases for MACK

See All Press Releases

Partner Headlines for MACK

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter